Metin Kurtoglu Selecta Biosciences Inc (SELB) insider trading activity

Metin Kurtoglu is Chief Technology Officer of SELECTA BIOSCIENCES INC. Currently has a direct ownership of 51,033 shares of SELB, which is worth approximately $42,867. The most recent transaction as insider was on Dec 10, 2024, when has been sold 2,901 shares (Common Stock) at a price of $24.35 per share, resulting in proceeds of $70,639. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51K

96.67% 3M change

n/a 12M change

Total Value Held $42,867

Metin Kurtoglu Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 10 2024	SELL Open market or private sale	$70,639 $24.35 p/Share	2,901 Reduced 5.38%	51,033 Common Stock
Dec 10 2024	BUY Exercise of conversion of derivative security	$4,090 $1.41 p/Share	2,901 Added 5.1%	53,934 Common Stock
Dec 09 2024	SELL Open market or private sale	$274,994 $25.55 p/Share	10,763 Reduced 17.42%	51,033 Common Stock
Dec 09 2024	BUY Exercise of conversion of derivative security	$15,175 $1.41 p/Share	10,763 Added 14.83%	61,796 Common Stock
Nov 21 2024	SELL Open market or private sale	$546,592 $16.67 p/Share	32,789 Reduced 39.12%	51,033 Common Stock
Nov 21 2024	BUY Exercise of conversion of derivative security	$46,232 $1.41 p/Share	32,789 Added 28.12%	83,822 Common Stock
Nov 20 2024	SELL Open market or private sale	$100,833 $17.69 p/Share	5,700 Reduced 10.05%	51,033 Common Stock
Nov 20 2024	BUY Exercise of conversion of derivative security	$8,036 $1.41 p/Share	5,700 Added 9.13%	56,733 Common Stock
Nov 19 2024	SELL Open market or private sale	$3,900 $19.5 p/Share	200 Reduced 0.39%	51,033 Common Stock
Nov 19 2024	BUY Exercise of conversion of derivative security	$282 $1.41 p/Share	200 Added 0.39%	51,233 Common Stock
Nov 18 2024	SELL Open market or private sale	$632,616 $18.39 p/Share	34,400 Reduced 40.27%	51,033 Common Stock
Nov 18 2024	BUY Exercise of conversion of derivative security	$48,504 $1.41 p/Share	34,400 Added 28.71%	85,433 Common Stock
Nov 15 2024	SELL Open market or private sale	$379,569 $17.2 p/Share	22,068 Reduced 30.19%	51,033 Common Stock
Nov 15 2024	BUY Exercise of conversion of derivative security	$31,115 $1.41 p/Share	22,068 Added 23.19%	73,101 Common Stock
Nov 14 2024	SELL Open market or private sale	$432,530 $16.7 p/Share	25,900 Reduced 33.67%	51,033 Common Stock
Nov 14 2024	BUY Exercise of conversion of derivative security	$36,519 $1.41 p/Share	25,900 Added 25.19%	76,933 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	1,531,000 Added 50.0%	1,531,000 Common Stock

Metin Kurtoglu

Chief Technology Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SELB shares.

Notify only if

Value

Insider Trading

Get notified when an Selecta Biosciences Inc insider buys or sells SELB shares.

Notify only if

Operation

Value

Type

News

Receive news related to SELECTA BIOSCIENCES INC

Track Activities on SELB

Account